ACP
CLYM

Acuta Capital Partners’s Climb Bio, Inc. Common Stock CLYM Stock Holding History

Acuta Capital Partners’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-54,000
Closed -$275K – 49
2024
Q3 		$275K Buy
+54,000
New +$275K 0.22% 37